These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 3936444)

  • 21. [The evolution of the arterial pressure during a stress test in patients with hypertrophic myocardiopathy].
    Bronze L; Santos L; Ventosa A; Ferreira J; Palos JL; Mendes M; Bonhorst D; Seabra-Gomes R
    Rev Port Cardiol; 1995 Sep; 14(9):629-36. PubMed ID: 7576763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of percutaneous transluminal septal myocardial ablation for obstructive hypertrophic cardiomyopathy on systolic and diastolic left ventricular function assessed by pressure-volume loops.
    Meliga E; Steendijk P; Valgimigli M; Ten Cate FJ; Serruys PW
    Am J Cardiol; 2008 Apr; 101(8):1179-84. PubMed ID: 18394455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Nifedipine in the treatment of hypertrophic non-obstructive cardiomyopathy].
    Senn M; Hess OM; Krayenbühl HP
    Schweiz Med Wochenschr; 1982 Sep; 112(38):1312-7. PubMed ID: 6215710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Importance of atrioventricular synchrony in hypertrophic obstructive cardiomyopathy treated by cardiac pacing].
    Gras D; de Place C; Le Breton H; Leclercq C; Paillard F; Mabo P; Daubert C
    Arch Mal Coeur Vaiss; 1995 Feb; 88(2):215-23. PubMed ID: 7487270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Long-duration electrocardiographic recording in 33 patients with obstructive cardiomyopathy].
    Baille N; Aliot E; Perrot B; Ethévenot G; Neimann JL; Godenir JP; Gilgenkrantz JM; Faivre G
    Arch Mal Coeur Vaiss; 1984 Jul; 77(7):730-7. PubMed ID: 6433835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of propranolol and disopyramide on left ventricular function at rest and during exercise in hypertrophic cardiomyopathy.
    Hartmann A; Kühn J; Hopf R; Klepzig H; Standke R; Kober G; Maul FD; Hör G; Kaltenbach M
    Cardiology; 1992; 80(2):81-8. PubMed ID: 1611637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haemodynamic effects of nifedipine and propranolol in patients with hypertrophic obstructive cardiomyopathy.
    Landmark K; Sire S; Thaulow E; Amlie JP; Nitter-Hauge S
    Br Heart J; 1982 Jul; 48(1):19-26. PubMed ID: 7200796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Acute effects of propranolol on the abnormal diastolic hemodynamics of the left ventricle in hypertrophic cardiomyopathy (author's transl)].
    Koga Y; Akiyoski T; Nagae K; Mizobuchi H; Toshima H
    Kokyu To Junkan; 1978 May; 26(5):473-6. PubMed ID: 351757
    [No Abstract]   [Full Text] [Related]  

  • 29. Disopyramide in hypertrophic cardiomyopathy. II. Noninvasive assessment after oral administration.
    Pollick C
    Am J Cardiol; 1988 Dec; 62(17):1252-5. PubMed ID: 3057852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The natural history of left ventricular hypertrophy in hypertrophic cardiomyopathy: an electrocardiographic study.
    McKenna WJ; Borggrefe M; England D; Deanfield J; Oakley CM; Goodwin JF
    Circulation; 1982 Dec; 66(6):1233-40. PubMed ID: 6128085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term propranolol therapy in muscular subaortic stenosis.
    Adelman AG; Shah PM; Gramiak R; Wigle ED
    Br Heart J; 1970 Nov; 32(6):804-11. PubMed ID: 5212354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term medical management of hypertrophic cardiomyopathy: usefulness of propranolol.
    Frank MJ; Abdulla AM; Watkins LO; Prisant L; Stefadouros MA
    Eur Heart J; 1983 Nov; 4 Suppl F():155-64. PubMed ID: 6686531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Surgical treatment of congenital aortic valve constriction with associated obstructive cardiomyopathy. Perioperative left intraventricular gradient treated with beta blockers. Apropos of a case].
    Latour F; Garabedian V; Barrière JC; Marchand M; Castellani L; Brochier M
    Arch Mal Coeur Vaiss; 1983 Feb; 76(2):227-32. PubMed ID: 6134502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exercise performance in hypertrophic cardiomyopathies.
    Lösse B; Kuhn H; Loogen F; Schulte HD
    Eur Heart J; 1983 Nov; 4 Suppl F():197-208. PubMed ID: 6686536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of propranolol on response to exercise in hypertrophic obstructive cardiomyopathy.
    Edwards RH; Kristinsson A; Warrell DA; Goodwin JF
    Br Heart J; 1970 Mar; 32(2):219-25. PubMed ID: 5462284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypertrophic cardiomyopathy: long-term effects of propranolol versus verapamil in preventing sudden death in "low-risk" patients.
    Pelliccia F; Cianfrocca C; Romeo F; Reale A
    Cardiovasc Drugs Ther; 1990 Dec; 4(6):1515-8. PubMed ID: 2081144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rhythm disturbances in hypertrophic cardiomyopathies: relationship to symptoms and the effect of 'complete' beta blockade.
    Frank MJ; Stefadouros MA; Watkins LO; Prisant LM; Abdulla AM
    Eur Heart J; 1983 Nov; 4 Suppl F():235-43. PubMed ID: 6686541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Case of Infantile Mitochondrial Cardiomyopathy Treated with a Combination of Low-Dose Propranolol and Cibenzoline for Left Ventricular Outflow Tract Stenosis.
    Shimozawa H; Sato T; Osaka H; Takeda A; Miyauchi A; Omika N; Yada Y; Kono Y; Murayama K; Okazaki Y; Kishita Y; Yamagata T
    Int Heart J; 2022 Sep; 63(5):970-977. PubMed ID: 36104228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Propranolol in management of muscular subaortic stenosis.
    Sloman G
    Br Heart J; 1967 Sep; 29(5):783-7. PubMed ID: 6068465
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of hypertrophic myocardiopathies].
    Bouhour JB
    Presse Med; 1986 Sep; 15(32):1613-4. PubMed ID: 2949206
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.